A detailed history of Capital Financial Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Financial Services, LLC holds 6,210 shares of ABBV stock, worth $1.09 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares
6,210
Previous 6,425 3.35%
Holding current value
$1.09 Million
Previous $862,000 16.47%
% of portfolio
1.39%
Previous 1.27%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$138.31 - $165.87 $29,736 - $35,662
-215 Reduced 3.35%
6,210 $0
Q3 2022

Nov 08, 2022

SELL
$134.21 - $153.93 $1,342 - $1,539
-10 Reduced 0.16%
6,425 $862,000
Q3 2021

Jul 28, 2022

BUY
$106.4 - $120.78 $23,940 - $27,175
225 Added 3.62%
6,435 $694,000
Q2 2021

Jul 28, 2022

SELL
$105.21 - $117.21 $8,416 - $9,376
-80 Reduced 1.27%
6,210 $699,000
Q4 2020

Jul 28, 2022

BUY
$80.49 - $108.67 $506,282 - $683,534
6,290 New
6,290 $674,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Financial Services, LLC Portfolio

Follow Capital Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Financial Services, LLC with notifications on news.